Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Recordati Industria Chimica E Farmaceutica S.P.A. (RCDTF) had Stock-Based Compensation of $5.57M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$834.99M |
|
$179.14M |
|
$237.12M |
|
$597.87M |
|
$566.26M |
|
$268.73M |
|
$-33.77M |
|
$234.96M |
|
$234.96M |
|
$179.14M |
|
$179.14M |
|
$179.14M |
|
$179.14M |
|
$268.73M |
|
$330.13M |
|
204.08M |
|
209.11M |
|
$0.88 |
|
$0.86 |
|
| Balance Sheet Financials | |
$2.02B |
|
$268.21M |
|
$4.22B |
|
$6.24B |
|
$1.60B |
|
$2.06B |
|
$2.23B |
|
$3.83B |
|
$2.41B |
|
$-1.34B |
|
$2.41B |
|
-- |
|
| Cash Flow Statement Financials | |
$120.40M |
|
$-18.70M |
|
$-166.38M |
|
$501.90M |
|
$445.30M |
|
$-56.60M |
|
|
Stock-Based Compensation |
$5.57M |
$-0.25M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.26 |
|
-- |
|
-- |
|
0.46 |
|
1.15 |
|
71.60% |
|
32.18% |
|
32.18% |
|
-- |
|
28.14% |
|
21.45% |
|
$107.81M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.37 |
|
0.93 |
|
96.47 |
|
7.43% |
|
-13.32% |
|
2.87% |
|
4.01% |
|
-- |
|
$0.52 |
|
$0.58 |
|